Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04386096 · ClinicalTrials.gov registry record · NA
Web Based Tools to Improve Medication Continuity in Adolescents With ADHD
A NA study, sponsored by Children's Hospital Medical Center, Cincinnati.
- Completed
- Registry status
- NA
- Development phase
- 40
- Enrollment target
NCT04386096 is a NA study that has completed, run by Children's Hospital Medical Center, Cincinnati. The registered enrollment target is 40 participants.
The verdict
NCT04386096, a NA study, has completed, sponsored by Children's Hospital Medical Center, Cincinnati.
- COMPLETED
- Registry status
- NA
- Development phase
- 40 participants
- Enrollment target
Study Summary
Medication is an efficacious treatment strategy for adolescents with attention-deficit/hyperactivity disorder (ADHD), however use significantly declines during adolescence when the consequences of ADHD are most severe (e.g. dropping out of school, delinquency, etc.). The Unified Theory of Behavior Change (UTBC) has been proposed as a conceptual model to explain the mechanism underlying ADHD medication adherence and to guide the development of interventions to improve the continuity of treatment. The UTBC is a well-established and empirically tested model that identifies factors that influence an individual's intention to perform a behavior as well as factors that influence whether a behavior is actually carried out. Indeed, the research team's preliminary data support the relevance of pre-intention factors and implementation factors for medication continuity among adolescents with ADHD. Currently, no evidence-based interventions target medication continuity for adolescents with ADHD. The objective of this study is to test a multi-component intervention that systematically identifies and targets aspects of the UTBC model most relevant for each adolescent with poor ADHD medication continuity. The central hypothesis is that the tailored intervention will support ADHD medication continuity. The study will objectively test the central hypothesis by conducting a randomized controlled trial among adolescents with poor medication continuity to test whether the intervention engages the mechanism underlying medication continuity and improves outcomes.
Interventions
- OTHER Mehealth for ADHD software with medication continuity tools
- OTHER Mehealth for ADHD software with no medication continuity tools
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 40 participants |
| Start Date | 2020-06-01 |
| Est. Completion | 2021-05-24 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04386096
The ClinicalTrials.gov registry entry for NCT04386096 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 40 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Children's Hospital Medical Center, Cincinnati, which has 571 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Mehealth for ADHD software with medication continuity tools is the first listed.
NCT04386096 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04386096 about?
NCT04386096 is a clinical study titled "Web Based Tools to Improve Medication Continuity in Adolescents With ADHD". Medication is an efficacious treatment strategy for adolescents with attention-deficit/hyperactivity disorder (ADHD), however use significantly declines during adolescence when the consequences of ADHD are most severe (e.g. dropping out of school, delinquency, etc.). The Unified Theory of Behavior C...
What is the current status of trial NCT04386096?
This trial is currently completed. It is a NA study. The enrollment target is 40 participants. The study started on 2020-06-01. Estimated completion is 2021-05-24.
What interventions are being tested in trial NCT04386096?
The interventions under investigation include: Mehealth for ADHD software with medication continuity tools (OTHER), Mehealth for ADHD software with no medication continuity tools (OTHER).
Who is sponsoring clinical trial NCT04386096?
This trial is sponsored by Children's Hospital Medical Center, Cincinnati, which has 571 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.